Pranil Pawar is a B.Tech Computer Science and Engineering (Data Science) student and aspiring AI entrepreneur from India. He is passionate about developing technology-driven solutions for real-world healthcare challenges. His interests include artificial intelligence, computer vision, IoT, and emergency response systems. Pranil has worked on AI-based healthcare and automation projects and aims to improve rural healthcare accessibility through innovative, scalable technologies.

I am a PhD researcher specializing in snake venom diagnostics, biomarker discovery, and the development of aptamer- and antibody-based platforms for precision snakebite management. My research integrates venom proteomics, SELEX-based aptamer selection, recombinant protein production, mass spectrometry, and lateral flow assay development to identify and validate species-specific venom biomarkers and translate them into point-of-care diagnostic platforms. I have experience in biosensor development.

Exalt Impact Network is a faith-based, community-driven nonprofit organization in Kenya committed to improving lives through innovative, evidence-based solutions. We work across health, education, livelihoods, environmental stewardship, leadership, and community resilience, partnering with local communities, faith institutions, government, and other stakeholders. Our approach combines biblical & scientific best practices with trusted community networks to address pressing social challenges.

Operations Director with deep experience in scaling and transforming service organizations. Skilled in operational transformation, benchmarking and innovation with a track record of building resilient systems. Passionate about applying practical solutions to complex challenges, I am now developing a healthcare response and logistics model -- aiming to improve patient pathways, emergency preparedness and critical care coordination.

Oncosimis Biotech is an Indian biotechnology organization focused on making advanced biologic medicines affordable for patients. It develops and produces biosimilars and other protein‑based treatments using its own AcceTT and BacSec technology platforms, which help make high‑quality medicines efficiently and at lower cost. By using AcceTT for mammalian cell products and BacSec for microbial protein production, the organization aims to bring modern targeted therapies within reach of more people.

A young mid-career researcher, a physician with special interest in tropical diseases and a traineer clinical pharmacologist with interested in clinical toxicology which entails management of neglected tropical snakebite. My current research interest is at the intersection of snakebite management, infectious diseases and antimicrobial resistance.

Genix.ai is a 4 years old startup with team from diverse backgrounds like Bioinformatics, Cloud, AI, IoT, Automation and enterprise level software engineering. Founder Gnanavel Mutharasu is former researchers from Indian Institute of Science and PhD scholar from Tampere University, Finland.

I, Dr. Edward Kareithi Githinji, PhD, am an Assistant Principal Research Scientist and Head of the Taveta Research Unit at the Kenya Medical Research Institute (KEMRI). I am a medical parasitologist/ entomologist with over 29 years of experience in research, teaching, and public health. My work focuses on malaria, NTDs, vector biology, One Health, and AI-enabled digital health innovations. I have led and contributed to numerous national and internationally funded projects.

I am a Rwandan clinical psychologist, researcher, and data analyst, currently in the final year of my PhD. I also serve as an academic editor for PLOS ONE. My expertise includes mental health, behavioural science, public health research, intervention development and evaluation, and advanced quantitative data analysis. I have contributed to more than 40 peer-reviewed publications addressing areas such as trauma, community mental health, treatment adherence, chronic health conditions, and health interventions in resource-limited settings.

PhD in Biochemistry and Immunology with expertise in developing polymer- and small-molecule-based solutions for treating envenomation from scorpion, spider, and snake bites. Specialized in field-ready treatments for South American venom accidents, bridging laboratory innovation with real-world emergency care.